AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 339 filers reported holding AVANOS MED INC in Q1 2019. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -33.3% | 77 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 77 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -54.6% | 77 | -63.7% | 0.00% | – |
| Q3 2021 | $6,614 | -14.2% | 212 | 0.0% | 0.00% | – |
| Q2 2021 | $7,710 | -16.9% | 212 | 0.0% | 0.00% | – |
| Q1 2021 | $9,273 | -4.7% | 212 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $9,727 | +38.1% | 212 | 0.0% | 0.00% | – |
| Q3 2020 | $7,043 | +13.0% | 212 | 0.0% | 0.00% | – |
| Q2 2020 | $6,231 | +9.1% | 212 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $5,709 | -20.1% | 212 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $7,144 | -10.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,942 | -14.1% | 212 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $9,245 | -9.4% | 212 | -11.3% | 0.00% | 0.0% |
| Q1 2019 | $10,201 | -4.7% | 239 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,705 | -39.0% | 239 | -6.6% | 0.00% | -50.0% |
| Q3 2018 | $17,536 | – | 256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |